104 related articles for article (PubMed ID: 25565272)
1. Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma.
Barbieri RB; Bufalo NE; Secolin R; Assumpção LV; Maciel RM; Cerutti JM; Ward LS
Eur J Endocrinol; 2014 Dec; 171(6):761-7. PubMed ID: 25565272
[TBL] [Abstract][Full Text] [Related]
2. Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma.
Barbieri RB; Bufalo NE; Secolin R; Silva AC; Assumpção LV; Maciel RM; Cerutti JM; Ward LS
Eur J Endocrinol; 2012 Feb; 166(2):241-5. PubMed ID: 22048975
[TBL] [Abstract][Full Text] [Related]
3. Additive effect of RET polymorphisms on sporadic medullary thyroid carcinoma susceptibility and tumor aggressiveness.
Ceolin L; Siqueira DR; Ferreira CV; Romitti M; Maia SC; Leiria L; Crispim D; Ashton-Prolla P; Maia AL
Eur J Endocrinol; 2012 May; 166(5):847-54. PubMed ID: 22345297
[TBL] [Abstract][Full Text] [Related]
4. Modulatory Role of Single Nucleotide Polymorphisms of Distinct Genetic Pathways on Clinical Behavior of Medullary Thyroid Carcinoma.
Mishra V; Kowtal P; Rane P; Sarin R
Asian Pac J Cancer Prev; 2020 May; 21(5):1289-1293. PubMed ID: 32458635
[TBL] [Abstract][Full Text] [Related]
5. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.
Gayther SA; Song H; Ramus SJ; Kjaer SK; Whittemore AS; Quaye L; Tyrer J; Shadforth D; Hogdall E; Hogdall C; Blaeker J; DiCioccio R; McGuire V; Webb PM; Beesley J; Green AC; Whiteman DC; ; Goodman MT; Lurie G; Carney ME; Modugno F; Ness RB; Edwards RP; Moysich KB; Goode EL; Couch FJ; Cunningham JM; Sellers TA; Wu AH; Pike MC; Iversen ES; Marks JR; Garcia-Closas M; Brinton L; Lissowska J; Peplonska B; Easton DF; Jacobs I; Ponder BA; Schildkraut J; Pearce CL; Chenevix-Trench G; Berchuck A; Pharoah PD;
Cancer Res; 2007 Apr; 67(7):3027-35. PubMed ID: 17409409
[TBL] [Abstract][Full Text] [Related]
6. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
Siqueira DR; Romitti M; da Rocha AP; Ceolin L; Meotti C; Estivalet A; Puñales MK; Maia AL
Endocr Relat Cancer; 2010 Dec; 17(4):953-63. PubMed ID: 20801952
[TBL] [Abstract][Full Text] [Related]
7. Genetic risk association of CDKN1A and RET gene SNPs with medullary thyroid carcinoma: Results from the largest MTC cohort and meta-analysis.
Mishra V; Kowtal P; Rane P; Sarin R
Cancer Med; 2019 Oct; 8(13):6151-6161. PubMed ID: 31408923
[TBL] [Abstract][Full Text] [Related]
8. CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.
Pasquali D; Circelli L; Faggiano A; Pancione M; Renzullo A; Elisei R; Romei C; Accardo G; Coppola VR; De Palma M; Ferolla P; Grimaldi F; Colao A; Colantuoni V
Eur J Endocrinol; 2011 Mar; 164(3):397-404. PubMed ID: 21177330
[TBL] [Abstract][Full Text] [Related]
9. [RET and GFRA1 germline polymorphisms in medullary thyroid cancer patients].
Severskaia NV; Saenko VA; Il'in AA; Chebotareva IV; Rumiantsev PO; Isaev PA; Medvedev VS; Iasmita S
Mol Biol (Mosk); 2006; 40(3):425-35. PubMed ID: 16813162
[TBL] [Abstract][Full Text] [Related]
10. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.
Kibel AS; Suarez BK; Belani J; Oh J; Webster R; Brophy-Ebbers M; Guo C; Catalona WJ; Picus J; Goodfellow PJ
Cancer Res; 2003 May; 63(9):2033-6. PubMed ID: 12727815
[TBL] [Abstract][Full Text] [Related]
11. Analysis of somatic mutations in BRAF, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma.
Nascimento FP; Cardoso MG; Lindsey SC; Kunii IS; Valente FO; Kizys MM; Delcelo R; Camacho CP; Maciel RM; Dias-Da-Silva MR
Mol Med Rep; 2016 Feb; 13(2):1653-60. PubMed ID: 26718898
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
[TBL] [Abstract][Full Text] [Related]
13. Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma.
El Naofal M; Kim A; Yon HY; Baity M; Ming Z; Bui-Griffith J; Tang Z; Robinson M; Grubbs EG; Cote GJ; Hu P
Ann Clin Lab Sci; 2017 Sep; 47(5):523-528. PubMed ID: 29066476
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide copy number analysis in a family with p.G533C RET mutation and medullary thyroid carcinoma identified regions potentially associated with a higher predisposition to lymph node metastasis.
Araujo AN; Moraes L; França MI; Hakonarson H; Li J; Pellegrino R; Maciel RM; Cerutti JM
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1104-12. PubMed ID: 24601688
[TBL] [Abstract][Full Text] [Related]
15. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
[TBL] [Abstract][Full Text] [Related]
16. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
Machens A; Dralle H
Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
[TBL] [Abstract][Full Text] [Related]
17. Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways.
Ameur N; Lacroix L; Roucan S; Roux V; Broutin S; Talbot M; Dupuy C; Caillou B; Schlumberger M; Bidart JM
Endocr Relat Cancer; 2009 Dec; 16(4):1261-72. PubMed ID: 19675075
[TBL] [Abstract][Full Text] [Related]
18. The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.
Weinhaeusel A; Scheuba C; Lauss M; Kriegner A; Kaserer K; Vierlinger K; Haas OA; Niederle B
Thyroid; 2008 Dec; 18(12):1269-76. PubMed ID: 18976163
[TBL] [Abstract][Full Text] [Related]
19. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma.
Iolascon A; Giordani L; Moretti A; Basso G; Borriello A; Della Ragione F
Hepatology; 1998 Apr; 27(4):989-95. PubMed ID: 9537438
[TBL] [Abstract][Full Text] [Related]
20. Global DNA methylation profile in medullary thyroid cancer patients.
Ceolin L; Goularte APP; Ferreira CV; Romitti M; Maia AL
Exp Mol Pathol; 2018 Aug; 105(1):110-114. PubMed ID: 29935954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
